Maximize Your Garden Time By Weeding Out Aches and Pains

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
90
Maximize Your Garden Time By Weeding Out Aches and Pains With Arnicare

NEWTOWN SQUARE, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Even pleasant pastimes can be painful. Gardening is one of many seasonal activities that can be enjoyable, but can also lead to muscle soreness and pain. Recent surveys show the most common source of neck and back pain during the warmer months is largely due to yard work. For relief, gardeners can turn to a homeopathic medicine called Arnicare to help ease muscle pain and stiffness, as well as reduce swelling from injuries and discoloration from bruising.

“There can be so many different sources of pain from our regular routines and activities, such as gardening, that it’s easy to overlook until the pain problem escalates,” said Dr. Ken Redcross, board-certified internal medicine physician. “It’s best to identify triggers of the muscle pain and soreness, then try lifestyle modifications and remedies from Mother Nature that are closer to the earth before taking numbing pain medication.”

Gardening pain can be caused by digging, lifting and moving heavy objects, and standing or squatting in strange positions for long periods of time. Most people, who enjoy gardening as a hobby, forget that this strenuous activity can take a toll on joints and muscles. And, although gardening is not a contact sport, Redcross advises to prepare for it like any other athletic activity.

Redcross recommends warming up the muscles and stretching before and after yard work to minimize strains, and limiting gardening activity to 20-30 minutes at a time to give muscles much needed breaks. He also recommends using Arnicare, a pain reliever made from Arnica montana, an ingredient from a specific type of mountain daisy that is harvested each summer in the French Alps.  Arnicare can help relieve lower back pain and muscle stiffness that often results after a long day of tending to the yard and garden beds.

Arnicare can be taken orally in the form of pellets that dissolve under the tongue or used topically as a gel or cream for relief of muscle pain and stiffness. It can be purchased over-the-counter at most pharmacies including CVS, Rite Aid and Walgreens as well as natural health stores nationwide. It’s also an affordable solution costing between $7-10 for the gels, creams and pellets. All Arnicare products are manufactured according to the high standards of drug Good Manufacturing Practices and conform to the Homeopathic Pharmacopoeia of the United States.

“It’s pretty amazing that you can manage muscle pain from an active ingredient that comes straight from nature’s garden,” said Redcross. “Gardening is quite therapeutic when done properly, and unmatched when it comes to the benefits of mind, body and spirit.”

To avoid further gardening pain, Redcross also recommends the following: Set attainable goals, be aware and take care when bending and reaching, ask for help often, use cushions under knees, work with long-handled tools to keep a better posture, switch up activities often to avoid repetitive-motion injuries, listen to one’s own body and take plenty of breaks. For more gardening tips, visit: www.arnicare.com .

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/Attachm...56cd4c801f

http://www.globenewswire.com/NewsRoom/Attachm...b462eb3f15

Media Contact: Amy Summers 212-757-3419 or Pitch Publicity

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Deadline Looms for Insulet Lawsuit Investors

Updated Category News Views 25

Tick Tock: Investors, Your Clock's Running Out We're not talking about your everyday hiccup here. Insulet Corporation (NASDAQ: PODD) investors have some major decisions to make fast. If there's one deadline you can't afford to sleep through, it's the one coming up on August 31, 2026. That's when folks who've taken a hit investing in Insulet are up to their necks in legal...

Continue Reading
Essential Strategies for Staying Cool This Summer on a Budget

Updated Category News Views 149

Essential Strategies for Staying Cool This Summer on a Budget C & C Heating & Air Conditioning emphasizes a comprehensive approach to reducing energy consumption and maintaining sustainability. C & C Heating & Air Conditioning, a renowned heating and cooling service provider with over seventy years of industry experience, suggests that homeowners can enjoy a cooler...

Continue Reading
F.N.B. Corporation Announces Quarterly Dividend of $0.12

Updated Category News Views 151

F.N.B. Corporation Dividend Announcement F.N.B. Corporation (NYSE: FNB) has officially announced the declaration of a quarterly cash dividend, set at $0.12 per share for its common stock. This move reflects the corporation's strong commitment to rewarding its shareholders and maintaining a solid financial foundation. Details of the Dividend Declaration The dividend is...

Continue Reading
Analyzing Visa's Competitive Edge in Financial Services

Updated Category News Views 231

Understanding Visa's Market Position In a world driven by financial innovation and fierce competition, it's essential for investors and enthusiasts to closely examine the players in the financial services sector. This article delves into Visa (NYSE: V) and contrasts its performance against that of its main competitors. By looking at crucial financial metrics, market...

Continue Reading
Ethereum's Staking Revolution: New Opportunities Await Investors

Updated Category News Views 187

Ethereum's Remarkable Growth and Staking Potential The digital currency scene is buzzing with excitement as Ethereum spot ETFs have recorded impressive weekly inflows reaching $515 million, a notable first in history. This surge in investment highlights Ethereum's growing reputation as a reliable asset favored alike by institutional and retail investors. The Impact of...

Continue Reading